We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Specific Leukocyte Count Predicts Bacteremia

By LabMedica International staff writers
Posted on 24 Nov 2010
A decrease in the absolute number of lymphocytes in a white blood cell (WBC) count is thought to be an indicator that the patient may have a bacterial infection in the blood. More...


Similarly, the neutrophil-lymphocyte count ratio (NLCR) has been shown as a simple promising method to evaluate systemic inflammation in critically ill patients. These two parameters may be better than conventional infection markers in an emergency care unit.

In a retrospective study carried out at the emergency department (ED) of the Jeroen Bosch Hospital, (Hertogenbosch; The Netherlands) examined consecutive patient records from adult patients (18 years or older) admitted to the ED over a seven month period from April to October 2005, with suspected community-acquired bacteremia. C-reactive protein (CRP) level, WBC count, neutrophil count, lymphocyte count, and NLCR were compared between 92 patients with positive blood cultures and an equal number of age and gender matched patients with negative blood cultures.

CRP levels were measured with a fully automated enzyme-linked immunoassay using an Aeroset 2.0 analyzer (Abbott Diagnostics; Santa Clara, CA, USA). WBC, neutrophil and lymphocyte counts were determined on a Sysmex XE-2100 hematology analyzer (Sysmex Corporation; Kobe, Japan). Significant differences between patients with positive and negative blood cultures were detected with respect to CRP level (176 ± 138 mg/L versus 116 ± 103 mg/L; lymphocyte count (0.8 ± 0.5 × 109/L versus 1.2 ± 0.7 × 109/L; and NLCR (20.9 ± 13.3 versus 13.2 ± 14.1). However, there were no significant differences regarding WBC count and neutrophil count. Sensitivity, specificity, positive and negative predictive values were highest for the NLCR (77.2%, 63.0%, 67.6% and 73.4%, respectively).

Culturing microorganisms is the most definitive way to confirm bacterial infections. Unfortunately, this gold standard is time consuming and may be influenced by several factors including previous antibiotic usage. The authors concluded that, "Absolute lymphocytopenia can be used in the prediction of infectious emergency admissions. Moreover, the ratio of neutrophil and lymphocyte counts (NLCR) has even higher value in predicting bacteremia. This marker is simple, easily obtained and calculated, easy to integrate in daily practice and without extra costs.” The study was published on October 29, 2010, in the journal Critical Care.

Related Links:

Jeroen Bosch Hospital
Abbott Diagnostics
Sysmex Corporation




Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.